FENNEC PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fennec Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 27.4M shares, a 2.96% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 27.4M +787K +2.96% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 27.3M +820K +3.09% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 27.1M +694K +2.63% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 27M +666K +2.53% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 26.6M +397K +1.51% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 26.5M +442K +1.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 26.4M +371K +1.43% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 26.4M +347K +1.33% Dec 31, 2022 10-K 2024-03-29
Q3 2022 26.2M +231K +0.89% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 26.1M +60K +0.23% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 26M +37K +0.14% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 26M +11K +0.04% Dec 31, 2021 10-K 2023-03-29
Q3 2021 26M +197K +0.76% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 26M +651K +2.57% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 26M +6.11M +30.7% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 26M +6.11M +30.7% Dec 31, 2020 10-K 2022-02-28
Q3 2020 25.8M +5.91M +29.7% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 25.4M +5.46M +27.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 19.9M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 19.9M 0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 19.9M +792K +4.15% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 19.9M +1.1M +5.86% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 19.9M +1.41M +7.64% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 19.9M +1.49M +8.07% Dec 31, 2018 10-K 2020-02-14
Q3 2018 19.1M +3.25M +20.5% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 18.8M +3.17M +20.3% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 18.5M +4.84M +35.5% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 18.4M +4.77M +34.9% Dec 31, 2017 10-K 2019-03-15
Q3 2017 15.9M +15.8M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 15.6M +1.99M +14.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 13.6M +2.64M +23.9% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 13.6M +2.7M +24.7% Dec 31, 2016 10-K 2018-03-28
Q3 2016 13.6K* -10.9M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 13.6M +2.72M +24.9% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 11M +11M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 10.9M +347K +3.28% Dec 31, 2015 10-K 2017-03-29
Q3 2015 10.9M +10.9M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 10.9M +10.9M Jun 30, 2015 10-Q 2015-08-11
Q1 2015 10.6K* -29.3M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 10.6M +874K +8.99% Dec 31, 2014 10-K 2016-03-28
Q3 2014 9.86K* +9.86K Sep 30, 2014 10-Q 2014-11-13
Q2 2014 29.5K* +29.5K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 29.3M +29.3M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 9.72M -15.4M -61.4% Dec 31, 2013 10-K 2015-03-31
Q3 2013 0 -25.2M -100% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 0 -25.2M -100% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 25.2K* -25.1M Mar 31, 2013 10-Q 2013-05-13
Q4 2012 25.2M +25.1M Dec 31, 2012 10-K 2014-03-31
Q3 2012 25.2M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 25.2M -428M -94.4% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 25.2M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 25.2K* -20.4M Dec 31, 2011 10-K 2013-04-01
Q3 2011 25.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 453M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 20.5M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.